- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03703661
Needle-Aspirated Compression Dressing Following Ostomy Reversal
October 12, 2018 updated by: Sang Won Lee, University of Southern California
Can a Low Cost, Simple Needle-Aspirated Compression Dressing Reduce Surgical Site Infection Rates of Primarily Closed Ileostomy and Colostomy Reversal Wounds?
Negative pressure wound dressings have been studied and shown to have applications in decreasing rates of surgical wound infections.
This study studies the effect of a low cost needle-aspirated negative pressure compression dressing on rates of wound infection at prior ostomy site in patients undergoing ostomy reversal surgery.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Negative Pressure Wound Therapy (NPWT) will be studied in colorectal surgery patients undergoing ostomy reversal surgery.
The immediate goal is to compare primary wound closure against primary closure with needle-aspirated compression dressing, and determine if risk of potential ostomy site wound infections is decreased.
The investigators would also like to evaluate if this compression dressing can increase prevalence of complete wound closure by 12 weeks (last planned clinic visit).
NPWT using a continuous suction device was shown to decrease surgical site infection (SSI) at ostomy reversal sites undergoing primary closure.
There is a lack of published literature studying NPWT dressings without an associated suction device.
The investigators will be using a low-cost simple needle-aspirated suction technique to provide negative pressure under a tegaderm/gauze dressing, at the time of placement.
Patients will be consented and randomized into a negative pressure group, or a control group consisting of the same dressing under normal pressure.
All adult patients undergoing ostomy reversal surgery who consent to the study will be included.
Exclusion criteria include prior recurrent skin infections, prior stoma-site infection, or large parastomal hernia.
Patients in the negative pressure group will have the pressure under the dressing measured immediately prior to removal on post-operative day 2.
Study Type
Interventional
Enrollment (Anticipated)
122
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90033
- University of Southern California
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- at least 18 years of age
- presence of a loop or end colostomy or ileostomy
- consenting to study and to ostomy reversal
Exclusion Criteria:
- altered mental status or patients unable to sign the informed consent form
- vulnerable patient populations such as prison and ward patients
- patients who are discovered before or during surgery as unable to undergo placement of compression dressing will be excluded.
- Patients with visible protrusion/evidence of large parastomal hernia
- history of recurrent skin & soft tissue infections
- history of previous stoma site infection or complications
- patients with extensive comorbidities (such as cancer involving stoma site, uncontrolled diabetes, etc), Crohn's patients and abdominal wall fistula patients
- patients in who primary closure of wound is deemed inappropriate by the operating surgeon, requiring a different method of stoma site wound management
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control
primary closure with gauze and adhesive/occlusive dressing
|
dressing consisting of gauze and adhesive/occlusive dressing, placed over wound after primary closure
|
Experimental: Negative Pressure
primary closure with gauze and adhesive/occlusive dressing under negative pressure
|
dressing consisting of Needle-Aspirated Negative Pressure dressing with gauze and adhesive/occlusive dressing, placed over wound after primary closure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgical Site Infection
Time Frame: 30 days post procedure
|
Surgical Site Infection
|
30 days post procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Wound Closure
Time Frame: 3 weeks post procedure and 12 weeks post procedure
|
rate of wound closure at 3 weeks post procedure and 12 weeks post procedure
|
3 weeks post procedure and 12 weeks post procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 27, 2017
Primary Completion (Anticipated)
August 1, 2019
Study Completion (Anticipated)
August 1, 2019
Study Registration Dates
First Submitted
October 9, 2018
First Submitted That Met QC Criteria
October 9, 2018
First Posted (Actual)
October 12, 2018
Study Record Updates
Last Update Posted (Actual)
October 17, 2018
Last Update Submitted That Met QC Criteria
October 12, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS-16-00812
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
IPD will not be made available outside the study group.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Site Infection
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemCompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site InfectionUnited States
-
Region SkaneVinnovaCompleted
-
MinaPharm PharmaceuticalsRecruitingSurgical Site InfectionsEgypt
-
Karolinska University HospitalStockholm South General HospitalRecruitingPostoperative Surgical Site InfectionSweden
-
Washington University School of MedicineCompleted
-
Singapore General HospitalNovem Healthcare Pte LtdTerminatedSuperficial Surgical Site InfectionSingapore
-
Halmstad County HospitalCompleted
-
Population Health Research InstituteActive, not recruitingSurgical Site InfectionsCanada
-
University of RochesterSage Products, Inc.Completed
-
Montefiore Medical CenterCompletedSurgical Site Infection Following Cesarean DeliveryUnited States
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted